Human SIRPA Alpha Monoclonal Antibody
Product Sizes
1 mg
£268.00
YR0021-1MG
5 mg
£746.00
YR0021-5MG
20 mg
£1442.00
YR0021-20MG
About this Product
- SKU:
- YR0021
- Additional Names:
- BIT|CD172A|MFR|MYD-1|P84|PTPNS1|SHPS1|SIRP|SIRPA
- Application:
- Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
- Clonality:
- Monoclonal
- Extra Details:
- Anzurstobart (CC-95251; BMS-986351) is a high-affinity, fully human monoclonal anti-SIRPA Alpha antibody that blocks the binding of CD47 to SIRPA Alpha. Anzurstobart enhances macrophage phagocytic activity against DLBCL cell lines in co-culture models when combined with the antibody Rituximab (HY-P9913). Anzurstobart has the potential for solid and hematologic malignancies research.
- Formulation:
- Purified from cell culture supernatant in an animal-free facility
- Immunogen:
- SIRPα
- Isotype:
- IgG1, kappa
- Molecular Weight:
- 150 kDa
- Purity:
- >95%
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Supplier:
- ABclonal Technology
- Type:
- Antibody: Biosimilar Antibody
- Manufacturer's Data Sheet:YR0021
